The groundbreaking approach of the medication represents a significant advance in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide164186.activosblog.com/40603598/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment